Christine Steffano
Family · San Antonio, TXNPI 1952826018
Payments from drug & device makers
Across 479 payments — averaging $14.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Novartis$1K
- Amgen$1K
- Johnson & Johnson$572
- AstraZeneca$523
- Pfizer$490
- plus $2K from 20 others
What the payments were for
- Food & beverage$6,858100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 123 | $1,305 |
| Novartis | 52 | $1,082 |
| Amgen(2 entities) | 81 | $1,044 |
| Johnson & Johnson | 73 | $572 |
| AstraZeneca | 12 | $523 |
| Pfizer | 42 | $490 |
| Lilly USA, LLC | 18 | $429 |
| UCB, Inc. | 20 | $319 |
| GSK | 21 | $295 |
| Janssen Scientific Affairs, LLC | 2 | $225 |
| Aurinia Pharma U.S., Inc. | 6 | $102 |
| Genentech USA, Inc. | 6 | $89 |
| Fresenius Kabi USA, LLC | 3 | $51 |
| Sanofi | 3 | $40 |
| Medtronic | 1 | $37 |
| Octapharma USA, Inc. | 2 | $35 |
| E.r. Squibb & Sons, L.L.C. | 2 | $33 |
| Ultragenyx Pharmaceutical Inc. | 2 | $32 |
| ANI Pharmaceuticals, Inc. | 2 | $32 |
| Boehringer Ingelheim | 2 | $27 |
| Almatica Pharma LLC | 1 | $23 |
| Grifols USA, LLC | 1 | $19 |
| Sobi, Inc | 1 | $16 |
| Radius Health, Inc. | 1 | $14 |
| Nevro Corp. | 1 | $13 |
| Kiniksa Pharmaceuticals, Ltd. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,858 in reported general payments places this provider in the 95th percentile of 15,456 family providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Humira(Cf) PenAdalimumab | 11 | $132,425 |
| Hydroxychloroquine Sulfate | 215 | $8,748 |
| Mycophenolate Mofetil | 45 | $3,969 |
| Leflunomide | 32 | $2,352 |
| MethotrexateMethotrexate Sodium | 99 | $1,864 |
| Mycophenolic AcidMycophenolate Sodium | 18 | $1,654 |
| Gabapentin | 41 | $880 |
| Celecoxib | 15 | $592 |
| Pregabalin | 18 | $537 |
| Tramadol Hcl | 43 | $495 |
| Prednisone | 47 | $441 |
| Duloxetine Hcl | 23 | $383 |
| Ibandronate Sodium | 12 | $339 |
| Azathioprine | 11 | $317 |
| Methylprednisolone | 37 | $242 |
Paid to pharmacies, not to this prescriber.
Other family in San Antonio
- Anna CastroSan Antonio$184K
- Natalia FariasSan Antonio$124K
- Ayoade AvworoSan Antonio$111K
- Tina CoppleSan Antonio$97K
- Kim HinojosaSan Antonio$63K
- Kimberly GibergaSan Antonio$36K
- Lashonda CraneHouston$3.4M
- David WeirDallas$959K
- Luba YammineHouston$479K
- Robin BeachHouston$428K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.